Manali Bhave

Patients transplanted for nonalcoholic steatohepatitis are at increased risk for postoperative cardiovascular events

Lisa B. VanWagner, Manali Bhave, Helen S. Te et al. · Hepatology · 2012 · 222 citations

Medicine, Internal Medicine, Surgery +17

Neratinib + fulvestrant + trastuzumab for HR-positive, HER2-negative, HER2-mutant metastatic breast cancer: outcomes and biomarker analysis from the SUMMIT trial

Komal Jhaveri, L.D. Eli, Hans Wildiers et al. · Annals of Oncology · 2023 · 61 citations · Full text

Medicine, Oncology, Pharmacology +17

Comprehensive genomic profiling of ESR1, PIK3CA, AKT1, and PTEN in HR(+)HER2(−) metastatic breast cancer: prevalence along treatment course and predictive value for endocrine therapy resistance in real-world practice

Manali Bhave, Júlia C.F. Quintanilha, Hanna Tukachinsky et al. · Breast Cancer Research and Treatment · 2024 · 40 citations · Full text

Medicine, Molecular Genetics, Oncology +17

A phase 1a/b trial of imlunestrant (LY3484356), an oral selective estrogen receptor degrader (SERD) in ER-positive (ER+) advanced breast cancer (aBC) and endometrial endometrioid cancer (EEC): Monotherapy results from EMBER.

Komal Jhaveri, Rinath Jeselsohn, Elgene Lim et al. · Journal of Clinical Oncology · 2022 · 39 citations

Medicine, Oncology, Pharmacology +14

Systematic review and meta-analysis of selected toxicities of approved <i>ALK</i> inhibitors in metastatic non-small cell lung cancer

Rubens B. Costa, Ricardo Costa, Sarah Talamantes et al. · Oncotarget · 2018 · 38 citations · Full text

Medicine, Oncology, Pharmacology +15